GENE fundamentals
An in-depth look to Genetic Technologies Ltd operating, investing, and financing activities
GENE free cash flow for H2 24 is -3.74 M USD. For 2024, GENE free cash flow was -6.27 M USD and operating cash flow was -6.25 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM